Author:
Korhonen Katariina,Pastorekova Silvia
Reference31 articles.
1. Ahlskog JK, Dumelin CE, Trűssel S, Mårlind J, Neri D (2009) In vivo targeting of tumor- associated carbonic anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett 19:4851–4856
2. Chamberlain MC (1996) Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 84:733–736
3. Chiang WL, Chu SC, Yang SS, Li MC, Lai JC, Yang SF, Chiou HL, Hsieh YS (2002) The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. Cancer Lett 188:199–205
4. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracaranial meningioma. Neurosurgery 57:1088–1095
5. Grunberg SM, Rankin C, Townsend J, Ahmadi J, Feun L, Fredericks L, Russell C, Kabbinavar F, Barger GR, Stelzern KJ, Southwest Oncology Group, Burlington, VT, Southwest Oncology Group, San Antonio, TX, Eastern Cooperative Oncology Group, Brookline, MA (2001) Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable meningioma. Proc ASCO 20:222